Alyn Davies

Alyn Davies is an Associate Director at AstraZeneca, specializing in antibody drug conjugates (ADCs) and leading a team of medicinal chemists on key projects since May 2023. Previously, Alyn held roles at Pfizer as Principal Scientist and Senior Scientist, focusing on protein degradation programs and synthetic chemistry methodologies. Alyn's academic background includes a PhD in Asymmetric Organocatalysis from the University of St Andrews and a Master's in Chemistry from the University of Warwick. Additional experience includes postdoctoral research at the University of Oxford and early roles as a Lab Demonstrator and Discovery Chemistry Intern, showcasing a strong foundation in medicinal chemistry and research collaboration.